Health care stocks were edging higher pre-bell Friday as the Health Care Select Sector SPDR Fund (XLV) was slightly advancing and the iShares Biotechnology ETF (IBB) was up 0.4% recently.
Viatris (VTRS) shares were down more than 3% after the company said a phase 3 study evaluating the efficacy and safety of MR-139 ophthalmic ointment in subjects with blepharitis did not meet its primary endpoint of complete resolution of debris after six weeks of twice daily dosing.
Telomir Pharmaceuticals (TELO) shares were up more than 153% after the company said its lead candidate Telomir-1 may help restore a tumor suppressor in human prostate cancer cells.
Sarepta Therapeutics (SRPT) shares were down 25% following reports of another patient death in the company's gene therapy trial.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.